NL176562C - Werkwijze ter bereiding van een farmaceutisch preparaat dat een derivaat van 3-(coor)chinoline bevat en werkwijze voor de bereiding van deze verbindingen. - Google Patents
Werkwijze ter bereiding van een farmaceutisch preparaat dat een derivaat van 3-(coor)chinoline bevat en werkwijze voor de bereiding van deze verbindingen.Info
- Publication number
- NL176562C NL176562C NLAANVRAGE7206697,A NL7206697A NL176562C NL 176562 C NL176562 C NL 176562C NL 7206697 A NL7206697 A NL 7206697A NL 176562 C NL176562 C NL 176562C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparing
- coor
- quinoline
- derivative
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/48—Aldehydo radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D229/00—Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14430771A | 1971-05-17 | 1971-05-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7206697A NL7206697A (xx) | 1972-11-21 |
NL176562B NL176562B (nl) | 1984-12-03 |
NL176562C true NL176562C (nl) | 1985-05-01 |
Family
ID=22508010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7206697,A NL176562C (nl) | 1971-05-17 | 1972-05-17 | Werkwijze ter bereiding van een farmaceutisch preparaat dat een derivaat van 3-(coor)chinoline bevat en werkwijze voor de bereiding van deze verbindingen. |
Country Status (20)
Country | Link |
---|---|
US (1) | US3753993A (xx) |
JP (2) | JPS5550951B1 (xx) |
AR (1) | AR211508A1 (xx) |
AT (1) | AT325616B (xx) |
AU (1) | AU458565B2 (xx) |
BE (1) | BE783562A (xx) |
CA (1) | CA996117A (xx) |
CH (1) | CH565789A5 (xx) |
DE (1) | DE2224090C2 (xx) |
DK (1) | DK140895B (xx) |
ES (1) | ES402772A1 (xx) |
FI (1) | FI52221C (xx) |
FR (1) | FR2138003B1 (xx) |
GB (1) | GB1346724A (xx) |
IL (1) | IL39444A (xx) |
NL (1) | NL176562C (xx) |
NO (2) | NO136150C (xx) |
PH (2) | PH11670A (xx) |
SE (2) | SE385585B (xx) |
ZA (1) | ZA723266B (xx) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5336478B2 (xx) * | 1972-08-14 | 1978-10-03 | ||
US4008237A (en) * | 1972-07-14 | 1977-02-15 | Sumitomo Chemical Company, Limited | 2,3,5,8-Tetrahydro-5-alkoxy-8-oxofuro(2,3-g)quinoline-7-carboxylic acid derivatives |
US3962443A (en) * | 1972-08-14 | 1976-06-08 | Dainippon Pharmaceutical Co., Ltd. | Antibacterial pharmaceutical compositions and processes for preparation thereof |
DE2358909A1 (de) * | 1973-11-27 | 1975-05-28 | Boehringer Mannheim Gmbh | Cyclopenteno-chinolonderivate und verfahren zur herstellung derselben |
US4007193A (en) * | 1975-09-08 | 1977-02-08 | Warner-Lambert Company | Substituted 3-(2-pyridinyl)-4(1H)-quinolinone N-oxides |
US4147788A (en) * | 1976-02-23 | 1979-04-03 | E. I. Dupont De Nemours And Company | Antibacterials: 1-difluoromethyl-6,7-methylenedioxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and its esters |
US4284777A (en) * | 1978-12-26 | 1981-08-18 | E. I. Du Pont De Nemours And Company | Antibacterials: 1-difluoromethyl-6,7-methylenedioxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and its esters |
US4317827A (en) * | 1980-05-27 | 1982-03-02 | Sterling Drug Inc. | 4-[4(or 3)-Acylaminophenyl]pyridines and their use as cardiotonics |
US4376775A (en) * | 1980-05-27 | 1983-03-15 | Sterling Drug Inc. | N-[4-(4-Pyridinyl)phenyl]ureas and their cardiotonic use |
US4297363A (en) * | 1980-07-21 | 1981-10-27 | Sterling Drug Inc. | 2-Amino-3(4 or 5)-(pyridinyl)phenols and their use as cardiotonics |
US4533735A (en) * | 1981-09-08 | 1985-08-06 | Ethyl Corporation | Process for preparing antibacterial compounds |
US4490535A (en) * | 1981-09-08 | 1984-12-25 | Ethyl Corporation | 4-(3- and 4-Chlorocyclohex-3-enyl)pyridine intermediates |
US5281612A (en) * | 1982-09-09 | 1994-01-25 | Warner-Lambert Company | Naphthyridine antibacterial agents |
US4665079A (en) * | 1984-02-17 | 1987-05-12 | Warner-Lambert Company | Antibacterial agents |
IE55898B1 (en) * | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
US4526975A (en) * | 1983-07-08 | 1985-07-02 | Ethyl Corporation | 2-Amino-4-(4-pyridinyl)benzoic acids |
US4552966A (en) * | 1983-07-08 | 1985-11-12 | Ethyl Corporation | 2-Nitro-4-(4-pyridinyl) benzoic acids and derivatives |
US4649202A (en) * | 1983-07-08 | 1987-03-10 | Ethyl Corporation | Brominative aromatization of 4-cyclohexenylpyridines |
US4552964A (en) * | 1983-09-16 | 1985-11-12 | Ethyl Corporation | 4-(1-Chlorocyclohex-3-enyl)pyridines and preparation of 1-alkyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinolinecarboxylic acid |
US4554352A (en) * | 1983-09-29 | 1985-11-19 | Ethyl Corporation | Preparation of 1-alkyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinolinecarboxylic acid |
US4532326A (en) * | 1983-09-29 | 1985-07-30 | Ethyl Corporation | Decarboxylation process for preparing 4-(3-aminophenyl)pyridines |
US4571396A (en) * | 1984-04-16 | 1986-02-18 | Warner-Lambert Company | Antibacterial agents |
EP0179239A3 (en) * | 1984-09-17 | 1986-08-13 | Sterling Drug Inc. | 7-(pyridinyl)-/-alkyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid having antibacterial activity and preparation thereof |
US4698350A (en) * | 1984-09-17 | 1987-10-06 | Sterling Drug Inc. | 1-ethyl-6-fluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and antibacterial use thereof |
US4699984A (en) * | 1984-09-17 | 1987-10-13 | Sterling Drug Inc. | Preparation of intermediates to 6-fluoro-7-(2,6-dimethylpyridyl)quinoline carboxylic acids and compounds |
US4636506A (en) * | 1984-12-06 | 1987-01-13 | Pfizer, Inc. | 7-heterocyclic-1,4-dihydroquinolones |
US4797490A (en) * | 1984-12-06 | 1989-01-10 | Pfizer Inc. | Process for the preparation of 3-(2'-fluorophenyl)pyridine |
US4851535A (en) * | 1985-01-23 | 1989-07-25 | Toyama Chemical Co., Ltd. | Nicotinic acid derivatives |
AT392789B (de) * | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
US4761481A (en) * | 1985-03-18 | 1988-08-02 | Baxter Travenol Laboratories, Inc. | Substituted pyridine derivatives |
GB8512143D0 (en) * | 1985-05-14 | 1985-06-19 | Beecham Group Plc | Method of treatment |
AU594983B2 (en) * | 1985-10-29 | 1990-03-22 | Dainippon Pharmaceutical Co. Ltd. | Novel quinoline derivatives and processes for preparation thereof |
US4692454A (en) * | 1986-02-03 | 1987-09-08 | Warner-Lambert Company | Opthalmic use of quinolone antibiotics |
US5169853A (en) * | 1987-09-08 | 1992-12-08 | Sterling Drug Inc. | Pyridinyl-quinolone compounds, their preparation and use |
NZ225926A (en) * | 1987-09-08 | 1990-04-26 | Sterling Drug Inc | 7-pyridinyl-4-oxo-3-quinolinecarboxylic acid derivatives, and pharmaceutical compositions |
US5075319A (en) * | 1987-09-08 | 1991-12-24 | Sterling Drug Inc. | Pyridinyl-quinolone compounds, their preparation and use |
US4839355A (en) * | 1987-09-09 | 1989-06-13 | Sterling Drug Inc. | Tricyclic-pyridinylquinoline compounds, their preparation and use |
DE3811341A1 (de) * | 1987-10-09 | 1989-04-27 | Bayer Ag | In 7-stellung c-verknuepfte chinolon- und 1,8-naphthyridin-4-on-carbonsaeure und ein verfahren zu ihrer herstellung |
US4920120A (en) | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
US5585491A (en) * | 1988-01-25 | 1996-12-17 | Otsuka Pharmaceutical Co., Ltd. | Antibacterial agents |
KR910003630B1 (ko) * | 1988-06-17 | 1991-06-07 | 한국과학기술원 | 벤조일 아세틱 에스테르 유도체 및 그 제조방법 |
US5103040A (en) * | 1988-06-21 | 1992-04-07 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
US5233091A (en) * | 1988-06-21 | 1993-08-03 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
US5104868A (en) * | 1988-06-21 | 1992-04-14 | Pfizer Inc. | Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters |
US5039682A (en) * | 1988-06-21 | 1991-08-13 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
US7056917B2 (en) * | 2001-04-26 | 2006-06-06 | Daiichi Pharmaceutical Co., Ltd. | Drug efflux pump inhibitor |
EP1389463A4 (en) * | 2001-04-26 | 2008-09-17 | Daiichi Seiyaku Co | MEDICAMENT FOR INHIBITING A DRUG REMOVAL PUMP |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB830832A (en) * | 1957-02-15 | 1960-03-23 | Ici Ltd | New quinolones and therapeutic compositions containing them |
US3472859A (en) * | 1966-11-01 | 1969-10-14 | Sterling Drug Inc | 1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters |
US3542781A (en) * | 1968-12-23 | 1970-11-24 | Merck & Co Inc | 7-alkylamino 7-hydroxy quinoline 3-carboxylates |
-
1971
- 1971-05-17 US US00144307A patent/US3753993A/en not_active Expired - Lifetime
-
1972
- 1972-05-05 GB GB2101372A patent/GB1346724A/en not_active Expired
- 1972-05-15 ZA ZA723266A patent/ZA723266B/xx unknown
- 1972-05-15 IL IL39444A patent/IL39444A/en unknown
- 1972-05-16 NO NO1745/72A patent/NO136150C/no unknown
- 1972-05-16 SE SE7206409A patent/SE385585B/xx unknown
- 1972-05-16 DK DK242572AA patent/DK140895B/da not_active IP Right Cessation
- 1972-05-16 ES ES402772A patent/ES402772A1/es not_active Expired
- 1972-05-16 CA CA142,320A patent/CA996117A/en not_active Expired
- 1972-05-16 FI FI721385A patent/FI52221C/fi active
- 1972-05-16 AU AU42341/72A patent/AU458565B2/en not_active Expired
- 1972-05-16 PH PH13550A patent/PH11670A/en unknown
- 1972-05-16 CH CH726172A patent/CH565789A5/xx not_active IP Right Cessation
- 1972-05-17 AT AT431372A patent/AT325616B/de not_active IP Right Cessation
- 1972-05-17 JP JP4902172A patent/JPS5550951B1/ja active Pending
- 1972-05-17 DE DE2224090A patent/DE2224090C2/de not_active Expired
- 1972-05-17 BE BE783562A patent/BE783562A/xx not_active IP Right Cessation
- 1972-05-17 AR AR242039A patent/AR211508A1/es active
- 1972-05-17 FR FR7217588A patent/FR2138003B1/fr not_active Expired
- 1972-05-17 NL NLAANVRAGE7206697,A patent/NL176562C/xx not_active IP Right Cessation
-
1973
- 1973-02-12 NO NO566/73A patent/NO136929C/no unknown
-
1975
- 1975-01-31 PH PH16766A patent/PH11713A/en unknown
- 1975-06-19 SE SE7507123A patent/SE405009B/xx unknown
-
1979
- 1979-03-19 JP JP3217579A patent/JPS54135778A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
FI52221B (xx) | 1977-03-31 |
FR2138003B1 (xx) | 1975-10-17 |
FI52221C (fi) | 1977-07-11 |
SE385585B (sv) | 1976-07-12 |
IL39444A0 (en) | 1972-07-26 |
AT325616B (de) | 1975-10-27 |
NO136929B (no) | 1977-08-22 |
JPS5550951B1 (xx) | 1980-12-20 |
DE2224090C2 (de) | 1985-08-08 |
DE2224090A1 (de) | 1972-11-30 |
NL176562B (nl) | 1984-12-03 |
AR211508A1 (es) | 1978-01-30 |
NL7206697A (xx) | 1972-11-21 |
CH565789A5 (xx) | 1975-08-29 |
US3753993A (en) | 1973-08-21 |
ATA431372A (de) | 1975-01-15 |
AU458565B2 (en) | 1975-02-27 |
IL39444A (en) | 1976-10-31 |
NO136929C (no) | 1977-11-30 |
ES402772A1 (es) | 1975-11-01 |
SE7507123L (sv) | 1975-06-19 |
AU4234172A (en) | 1973-11-22 |
JPS54135778A (en) | 1979-10-22 |
JPS575234B2 (xx) | 1982-01-29 |
SE405009B (sv) | 1978-11-13 |
DK140895B (da) | 1979-12-03 |
PH11713A (en) | 1978-05-30 |
CA996117A (en) | 1976-08-31 |
PH11670A (en) | 1978-05-19 |
BE783562A (fr) | 1972-11-17 |
FR2138003A1 (xx) | 1972-12-29 |
NO136150C (no) | 1977-07-27 |
GB1346724A (en) | 1974-02-13 |
NO136150B (no) | 1977-04-18 |
ZA723266B (en) | 1973-03-28 |
DK140895C (xx) | 1980-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL176562C (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat dat een derivaat van 3-(coor)chinoline bevat en werkwijze voor de bereiding van deze verbindingen. | |
NL7501917A (nl) | Farmaceutisch preparaat en heterocyclische verbinding alsmede werkwijze voor het bereiden daarvan. | |
NL187102C (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat dat een 2-fenylimidazolidinon bevat, gevormd preparaat verkregen met deze werkwijze, alsmede werkwijze voor de bereiding van imidazolidinonen. | |
NL7608856A (nl) | Werkwijze ter bereiding van nieuwe tetrahydro- isochinoline derivaten alsmede deze verbindingen bevattende farmaceutische preparaten. | |
NL187210C (nl) | Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat, alsmede werkwijze voor het bereiden van een benzilzuur-ester van een n-gesubstitueerd nortropine-derivaat. | |
NL7507441A (nl) | Werkwijze voor het bereiden van een geneesmiddel, zo gevormd geneesmiddel en werkwijze voor het be- reiden van daartoe geschikte geneeskrachtige ver- bindingen. | |
NL167683B (nl) | Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat en werkwijze ter bereiding van n-acylfenylalanylamiden. | |
NL7609414A (nl) | Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van 1-sulfonylbenzimidazoolderivaten. | |
NL7612515A (nl) | Werkwijze ter bereiding van een geneesmiddel, zo gevormd geneesmiddel en werkwijze ter be- reiding van geneeskrachtige verbindingen. | |
NL184558C (nl) | Werkwijze voor het bereiden van een farmaceutisch preparaat, dat een moederkoornalkaloide bevat; farmaceutisch voorwerp. | |
NL183439C (nl) | Werkwijze voor de bereiding van een prostaglandine-bevattend gevriesdroogd poeder dat tevens polyvinylpyrrolidon bevat, alsmede werkwijze voor de bereiding van een geneesmiddel met prostaglandine-werking. | |
NL172953C (nl) | Werkwijze voor het bereiden en/of vervaardigen van een farmaceutisch preparaat dat een 4-omega-(cumarine-7-yloxy)-alkyl-piperazinederivaat bevat en werkwijze voor het bereiden van een dergelijk, voor therapeutische toepassing geschikt, derivaat. | |
NL164285C (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat, dat een imidazoÿ2.1-bÿthiazoolderivaat bevat, de gevormde farmaceutische preparaten, alsmede werkwijze voor het bereiden van dit imidazoÿ2.1-bÿthiazoolderivaat. | |
NL930134I1 (nl) | Werkwijze voor de bereiding van een 4-(2-acyloxy-3-aminopropoxy)indool en farmaceutisch preparaat dat deze verbinding bevat | |
NL7506210A (nl) | Werkwijze voor het bereiden van een 1h-tetra- zoolderivaat, alsmede geneesmiddelen waarin deze verbindingen zijn opgenomen. | |
NL187354C (nl) | Werkwijze voor de bereiding van farmaceutische preparaten met prostaglandinewerking en werkwijze voor de bereiding van daarin bruikbare prostaglandinederivaten. | |
NL7608164A (nl) | Werkwijze voor het bereiden van cefem- en penamverbindingen, alsmede werkwijze ter bereiding van farmaceutische preparaten. | |
NL172120C (nl) | Werkwijze voor het bereiden van een farmaceutisch of veterinair preparaat. | |
NL185203C (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat dat een prostaglandine-derivaat bevat en werkwijze voor de bereiding van een prostaglandine-derivaat. | |
NL190436C (nl) | Werkwijze ter bereiding van een farmaceutisch tabletvormig preparaat dat allopurinol bevat. | |
NL7900721A (nl) | Nieuwe derivaten van 1-naftylazijnzuur, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze verbindingen bevatten. | |
NL187909C (nl) | Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat met anti-aritmische werking dat een 1-aminoethoxy-3-aryloxy-2-hydroxypropaanderivaat en/of een zuuradditiezout daarvan bevat en werkwijze voor het bereiden van deze verbindingen en de zuuradditiezouten daarvan. | |
NL186768C (nl) | Werkwijze voor het bereiden van een farmaceutisch of veterinair preparaat, alsmede werkwijze voor het bereiden van daarbij als geneeskrachtige verbinding te gebruiken 3-oxo-5,6-dihydro-1,2,4-oxadiazinen. | |
NL7614015A (nl) | Werkwijze voor het bereiden van een farmaceu- tisch preparaat. | |
NL161150B (nl) | Werkwijze voor het bereiden van een geneesmiddel, alsmede verkregen gevormd geneesmiddel en werkwijze voor het bereiden van een benzofuranverbinding. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
V1 | Lapsed because of non-payment of the annual fee |